From a Swedish lab accident to a Lisbon breakthrough — the true story of how All-on-4 was invented, Nobel Biocare’s role, and why the technique’s history is your best evidence it works.
Patients researching full-arch implants eventually ask the quiet question behind all the others: is this actually proven, or am I the experiment? All-on-4’s answer lives in its history — a genuinely good story that runs from an accidental discovery in a Swedish laboratory, through a Lisbon clinician’s refusal to accept that resorbed jaws meant dentures forever, to one of the most-studied protocols in modern dentistry. Knowing the history isn’t trivia; it’s consent. Here’s how the treatment in your quote came to exist, who Nobel Biocare are, and what six decades of accumulated evidence means for the patient considering it in Melbourne today.
The foundation was an accident. Swedish researcher Per-Ingvar Brånemark, studying blood flow in bone healing, embedded titanium optical chambers in rabbit bone — and found, when the study ended, that he couldn’t remove them. The bone had fused to the titanium at a microscopic level. Brånemark named the phenomenon osseointegration, spent years verifying it wasn’t a fluke, and in 1965 placed the first titanium dental implants in a human volunteer — a Swedish man named Gösta Larsson, whose implants were still serving when he died more than forty years later. That single case remains dentistry’s favourite durability anecdote, but the deeper legacy was methodological: Brånemark insisted on decades of documentation before wide release, setting the evidence-first culture implant dentistry still inherits.
Discoveries need manufacturers. The Swedish company that industrialised Brånemark’s work — through mergers and renames eventually becoming Nobel Biocare — turned laboratory titanium into precision-manufactured implant systems: standardised fixtures, instruments and components produced to tolerances the technique demanded. Over the decades Nobel Biocare became one of the field’s reference manufacturers, its systems carried in thousands of published studies — which matters to a patient for one practical reason: an implant brand with a long research trail and global distribution means your fixture’s replacement parts and documentation will still exist in thirty years. It’s the difference between titanium with a pedigree and titanium with a price tag, a distinction our complete implant guide encourages every patient to probe.
By the 1990s single implants and small bridges were routine — for patients with bone. The patients most in need, though, were precisely those with least: long-term denture wearers whose back jaws had resorbed to slivers, whose sinuses had expanded downward, whose cases conventional protocols answered with heroic grafting — months of additional surgery, cost and healing before a single implant could even be placed. Many were simply refused. Full arches on six to eight vertical implants remained a treatment for the anatomically lucky, and the unlucky kept their dentures. That was the wall.
The breakthrough came from Lisbon, where Dr Paulo Maló asked the question that defines the technique: what if the implants tilted? By angling the two rear fixtures up to 45 degrees, they could run along the dense bone at the front of even a badly resorbed jaw — anchoring in what remained rather than grafting what didn’t — while their emergence points spread wide enough to support a full arch on just four implants. In 1998 Maló treated the first All-on-4 patient; the protocol added a second radical element — a fixed provisional bridge attached the same day, so patients left surgery with teeth. Working with Nobel Biocare, the technique was refined, componentised and studied at scale, with Maló’s clinic publishing outcome series that grew from dozens to thousands of patients across five, ten and eventually eighteen-plus year horizons — survival rates consistently in the mid-to-high ninety percents, the evidence base our lifespan guide summarises.
It’s worth remembering that All-on-4 was initially controversial — angled implants offended orthodoxy, and immediate loading contradicted the era’s wait-months rule. The scepticism was answered the only way dentistry accepts: independent replication. Clinics and universities worldwide ran their own cohorts; systematic reviews pooled them; and the survival curves kept agreeing with Lisbon’s. Twenty-five years on, the technique sits in mainstream prosthodontic practice globally — refined by CBCT-guided planning, digital design and materials like the zirconia bridge, but recognisably Maló’s protocol. For patients, that arc — radical idea, hostile scrutiny, decades of survived evidence — is precisely what “clinically proven” is supposed to mean.
Three practical inheritances. Predictability: your treatment plan rests on tens of thousands of documented cases, not optimism — the ranges quoted for healing, longevity and risk come from real cohorts. Componentisation: because the protocol grew up with major manufacturers, parts are standardised — the bridge fitted today can be serviced, repaired or upgraded decades hence. Questions with answers: ask any provider which implant system they use, why, and what its published record is — the history above is why good clinics answer instantly and vagueness is a red flag. At The Smile Designer we plan every full-arch case on CBCT imaging with systems chosen for exactly that documentation — the boring, verifiable kind of innovation.
All-on-4 hasn’t stood still; it’s been progressively de-risked. Planning moved from panoramic X-rays to CBCT 3D imaging, replacing anatomical guesswork with millimetre maps of bone and nerves. Surgery gained guided templates — 3D-printed from the digital plan, steering fixtures to their designed positions. Provisional bridges improved from hand-converted dentures to digitally pre-fabricated teeth waiting in theatre. And the definitive bridge evolved through reinforced acrylics to milled zirconia, extending renewal horizons dramatically. Variants matured alongside — All-on-6 for generous bone, zygomatic fixtures for the severest upper-jaw cases — so today’s consultation prescribes from a family of proven options, per our configuration guide, rather than one heroic technique. The protocol Maló drew in 1998 remains the skeleton; everything around it has been refined by a quarter-century of the profession’s scrutiny.
For the Melbourne patient comparing quotes, this story converts into a screening tool. Treatments with real histories generate real literature — so ask where a clinic’s claimed success rates come from, and expect an answer that references published cohorts rather than confidence. Implant systems with decades behind them guarantee parts and documentation into your seventies; brands without histories can’t. And clinicians formed inside the evidence culture — case selection, imaging, staged consent, scheduled follow-up — run recognisably different consultations from those selling packages. The history isn’t nostalgia; it’s the reason a $25,000 decision can be made on data. Sixty years of other people’s documented outcomes is the safest foundation any patient has ever had.
Portuguese clinician Dr Paulo Maló, who treated the first patient in Lisbon in 1998, developing and studying the protocol in partnership with implant manufacturer Nobel Biocare — building on Per-Ingvar Brånemark’s 1950s discovery of osseointegration.
Yes — it’s among the most-studied protocols in dentistry, with independent cohorts worldwide and systematic reviews reporting implant survival in the mid-to-high 90s percent at ten-plus years, and published follow-up extending beyond eighteen years.
The Swedish-origin implant manufacturer that industrialised Brånemark’s titanium implant work and later partnered with Maló on All-on-4 — one of the field’s reference brands, whose long research trail and parts continuity are why established systems matter to patients.
No — several established manufacturers produce well-documented full-arch systems. What matters is that your clinic names its system and that system carries a genuine published record; ask, and expect a direct answer.
Maló’s clinic followed its early cohorts for decades and published the outcomes — long-term series report the majority of original fixtures still functioning past ten and fifteen years, with bridge renewals handled as maintenance. Brånemark’s very first implant patient kept his fixtures for over forty years, a benchmark the field still cites.
The core protocol — four fixtures, tilted posteriors, same-day fixed teeth — is intact; everything around it has been refined: CBCT-guided planning, printed surgical templates, digital bridge design and zirconia finals. Today’s patient gets 1998’s insight with 2026’s tooling.
Sixty years of evidence, one appointment to apply it to your jaw. Book a full-arch consultation at The Smile Designer in Preston — and feel free to ask us the history questions too; we enjoy them.